Enhancing effects of α-, β-monoglycosylceramides on natural killer cell activity
✍ Scribed by Eiichi Kobayashi; Kazuhiro Motoki; Yasunori Yamaguchi; Takeshi Uchida; Hideaki Fukushima; Yasuhiko Koezuka
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 396 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0968-0896
No coin nor oath required. For personal study only.
✦ Synopsis
We examined the in vitro and in vivo natural killer (NK) cell activity enhancing effects of alpha-, beta-galactosylceramide (GalCer) and alpha-, beta-glucosylceramide (GluCer) which have the same ceramide moiety, and of other alpha-, beta-GalCer having a different ceramide portion, and found that alpha-types show stronger enhancing effects than beta-types and the alpha-GalCer possesses the most potent activity among GalCers and GluCers having the same ceramide moiety. When the comparison of tumor growth inhibitory effects of alpha, beta-GalCer on mice subcutaneously inoculated with B16 cells was performed, the alpha-GalCer showed stronger suppressive activity than its beta-type, paralleling their enhancing effects on NK cell activity. These results suggest that the manner of combination between sugar and ceramide plays an important role in antitumor activity as well as enhancing effect on NK cell activity of GalCers.
📜 SIMILAR VOLUMES
## Background: Adjuvant intraportal chemotherapy has been used with a view to prevent the development of metachronous hepatic metastases following curative resection for colorectal cancer. to evaluate the effects of this therapy on systemic antitumor immunological activity, 35 colorectal cancer pat
Hamsters were exposed to repeated or single doses of microwave energy and monitored for changes in core body temperature. circulating leukocyte profiles. serum corticosteroid levels. and natural killer (NKI cell activity in various tissues. NK cytotoxicity was measured in a "Crrelease assay employin